WASHINGTON, Oct 23 (Reuters) - Biopharmaceutical company ActivBiotics Inc. on Monday set its planned initial public offering at 4 million shares for between $12 and $14 each.
WASHINGTON, Oct 23 (Reuters) - Biopharmaceutical company ActivBiotics Inc. on Monday set its planned initial public offering at 4 million shares for between $12 and $14 each.